CARDIOVASCULAR (CV) RISK
Clinical trials for CARDIOVASCULAR (CV) RISK explained in plain language.
Never miss a new study
Get alerted when new CARDIOVASCULAR (CV) RISK trials appear
Sign up with your email to follow new studies for CARDIOVASCULAR (CV) RISK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Massive data study tests if Real-World records can mimic Gold-Standard heart trials
Knowledge-focused CompletedThis completed study looked at whether information from everyday healthcare claims can accurately predict the results of a large clinical trial (SURPASS-CVOT) that compared two diabetes drugs, tirzepatide and dulaglutide, for heart safety. Researchers analyzed records from over 4…
Matched conditions: CARDIOVASCULAR (CV) RISK
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 11:19 UTC
-
Red meat ban for 4 weeks: surprising changes in young hearts?
Knowledge-focused CompletedThis study tested whether healthy young adults who stop eating red and processed meat for four weeks show changes in their blood vessels and key health markers. Twelve participants replaced red meat with fish, eggs, or white meat while keeping their diet otherwise the same. Resea…
Matched conditions: CARDIOVASCULAR (CV) RISK
Phase: NA • Sponsor: Maria Clara Rocha • Aim: Knowledge-focused
Last updated May 26, 2026 11:08 UTC
-
Study reveals exercise effects in menopausal women
Knowledge-focused CompletedThis study looked at how a program of endurance training affects exercise ability in postmenopausal women who have trouble exercising. 43 women under 70 with unexplained shortness of breath participated. Researchers measured changes in fitness and muscle oxygen levels to understa…
Matched conditions: CARDIOVASCULAR (CV) RISK
Phase: NA • Sponsor: University of Poitiers • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC
-
Massive study digs into Real-World data to compare diabetes drugs for heart safety
Knowledge-focused CompletedThis study looked at health records from over 887,000 people with type 2 diabetes and overweight to compare two drugs—tirzepatide and semaglutide—for preventing heart attacks, strokes, or death. The goal was not to test a new treatment but to see if analyzing real-world data can …
Matched conditions: CARDIOVASCULAR (CV) RISK
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:13 UTC